Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

NCT00514085 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

NETWORK

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: recombinant human interleukin-21
OTHER: immunohistochemistry staining method
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

NCIC Clinical Trials Group

Collaborators

[object Object]